IL17A and rheumatoid arthritis: Similarly, the percentage of CD3+CD4+IL-17+IFN-γ+ cells was higher in BM of RA patients in comparison to BM of OA patients (0.2% vs 0.1%, p < 0.03) (Fig. 2c).